
Results
2
2 companies
Newron Pharmaceuticals
Market Cap: CHF 398.8m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 19.98
7D
3.1%
1Y
138.4%
Cosmo Pharmaceuticals
Market Cap: CHF 1.6b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 97.50
7D
-6.8%
1Y
61.4%